| |
| |
|
| Insider
Information: |
Wolf Geoffrey |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
124,500 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,570,925 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
124,500 |
|
|
| Total
Value |
$2,570,925 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Opiant Pharmaceuticals Inc |
OPNT |
10% Owner |
2018-04-08 |
124,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2018-04-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
90,000 |
124,500 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-28 |
4 |
OE |
$15.00 |
$1,742,250 |
D/D |
116,150 |
214,150 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-28 |
4 |
S |
$22.52 |
$968,360 |
D/D |
(43,000) |
98,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-27 |
4 |
S |
$21.51 |
$814,154 |
D/D |
(37,850) |
141,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-22 |
4 |
OE |
$15.00 |
$480,000 |
D/D |
32,000 |
178,850 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-21 |
4 |
OE |
$15.00 |
$1,635,000 |
D/D |
109,000 |
146,850 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-21 |
4 |
S |
$24.17 |
$483,400 |
D/D |
(20,000) |
37,850 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-20 |
4 |
S |
$22.75 |
$1,570,114 |
D/D |
(69,016) |
57,850 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-19 |
4 |
S |
$19.69 |
$75,807 |
D/D |
(3,850) |
127,647 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-19 |
4 |
OE |
$15.00 |
$567,900 |
D/D |
37,860 |
111,497 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-19 |
4 |
A |
$15.00 |
$567,900 |
D/D |
37,860 |
111,497 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-18 |
4 |
S |
$20.68 |
$561,131 |
D/D |
(27,134) |
73,637 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-14 |
4 |
OE |
$15.00 |
$300,000 |
D/D |
20,000 |
131,497 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-13 |
4 |
S |
$29.61 |
$231,076 |
D/D |
(7,804) |
100,771 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-08 |
4 |
S |
$30.40 |
$78,128 |
D/D |
(2,570) |
107,804 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-07 |
4 |
OE |
$5.00 |
$579,050 |
D/D |
80,374 |
110,374 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
10% Owner |
– – • |
2017-12-01 |
4 |
OE |
$15.00 |
$450,000 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • • |
2014-12-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
48,800 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
